John Cox

Overview

CEO of Dine Therapeutics; former CEO of BioVerative and senior leader at Biogen; expert on biotech organizational design and supply chain decision-making. John Cox serves as CEO of Dine Therapeutics and previously was CEO of BioVerative, a rare disease company spun out of Biogen that grew to over $1 billion in sales before being acquired by Sanofi. Cox holds an MBA from the University of Michigan and a master's degree in cell biology, and has held senior leadership roles at Biogen and Repertoire in addition to his CEO tenures. (Segment 1 (00:00-05:00))